SlideShare a Scribd company logo
Novità in ambito di diagnostica
molecolare nella
sensibilizzazione ad acari
Danilo Villalta
Immunologia e Allergologia
Ospedale «S. Maria degli Angeli»
Pordenone
OUTLINE
1. Note storiche e generalità sull’allergia agli
acari
2. Le molecole allergeniche degli acari:
gerarchia e proprietà
3. Lo spreading molecolare della risposta IgE
agli acari
4. La diagnostica classica e molecolare
nell’allergia ad acari
5. Possibile ruolo predittivo del pattern
anticorpale
OUTLINE
1. Note storiche e generalità sull’allergia agli
acari
2. Le molecole allergeniche degli acari:
gerarchia e proprietà
3. Lo spreading molecolare della risposta IgE
agli acari
4. La diagnostica classica e molecolare
nell’allergia ad acari
5. Possibile ruolo predittivo del pattern
anticorpale
Historical milestones
- As early as 1921 Kern RA reported that many asthmatics had strongly positive
skin test to house dust (Med Clin North Am 1921)
- In 1928 dr Dekker suggested that mites played an important role in allergy, but
this evidence was unconvincing (Munch Med Wochenschr 1928)
- In 1964 Woorhorst et al. identified Dermatophagoides pteronissinus as house
dust allergen (J Allergy 1967)
- In 1968 Brown described the first extract for dignostic skin test (Br Med J 1968)
- In 1971 extracts were available for immunotherapy (Smith AP. Br Med J 1971)
- In 1980 the first allergen of Dermatofagoides pteronissinus was described by
Chapman & Platts-Mills (J Immunol 1980)
- In 2013 was identified the molecular structure of the new major HDM allergen,
Der p 23 (Weghofer M, J Immunol 2013)
- The normal life span of a HDMs is approximately
65-100 days
- Proliferate maximally at a relative umidity of 75%
- Complete the egg-to-adulte cycle in 35 days at
23°C, but in only half time at 30°C
- Females lay approximately 50-80 eggs
during their lifetime
- Each immature mite stage need to shed
its exoskeleton before passing onto the
next stage
- During their lifetime mites produce
approximately 1000 solid fecal waste
particle (about 25 μ in diameter)
surrounded by a peritrophic membrane
containing proteolytic digestive enzymes
OUTLINE
1. Generalità sull’allergia agli acari
2. Le molecole allergeniche degli acari:
gerarchia e proprietà
3. Lo spreading molecolare della risposta IgE
agli acari
4. La diagnostica classica e molecolare
nell’allergia ad acari
5. Possibile ruolo predittivo del pattern
anticorpale
Schematic and still debated localization of the 12 examined
allergenic molecules of Dermatophagoides pteronyssinus.
1 15
18
11
21
14
23 7 5
4
2
1
22
Adapted and extended from
Weghofer M. J Immunol. 2013; 190:3059-67.
Banerjee S. J Invest Dermatol. 2015; 135:102-9.
Thomas WR. Allergol Int 2015; 64:304-11
Thomas WR. Chang Gung Med J. 2004; 27:563-9.
O'Neil SE. Clin Exp Allergy. 2006; 36:831-9.
Courtesy of P. Matricardi
Reithofer M & Jahn-Schmid B. Int J Mol Sci 2017.18,1368
Group 2
MD-2 like lipid binding protein
TSAI JJ PLOS 2011
«auto-adjuvant» properties
Miller JD. Clin Rev Allergy Immunol 2018, June 23
The «classical»
mite molecules
Cysteinprotease
Der p 1
Der p 2
Lipid binding protein
Der p 10
Tropomyosin
Trombone APF et al
CEA 2001;32:1323-8
- 95% HDM positive
- Accounting for 60%
of antibodies
J Immunol. 2013 April 1; 190(7): 3059–3067
Chitin-binding protein
Der p 23 is a protein of the peritrophic matrix that lines the midgut and surrounds
the digested food stuff and the fecal pellets. In mites, as in most Arthropods, fecal
pellets are surrounded by the peritrophic matrix. The peritrophic matrix is
synthesized along the whole midgut of the HDMs and functions as a permeability
barrier between the ingested food and midgut epithelium. It enhances digestive
processes and protects the midgut epithelium from mechanical disruption as well as
from attacks by toxins and pathogens. The peritrophic matrix is thought to be
secreted by the microvilli of gut epithelial cells and is composed of a meshwork of
chitin fibrils embedded in a matrix of proteins, proteoglycans, and glycoproteins. In
fact, the in situ localization suggests that Der p 23 is indeed synthesized in the
midgut epithelial cells where the allergen is localized in vesicles.
It reacted with IgE Abs from 74% of D.
pteronyssinus allergic patients (n = 347) at
levels comparable to the two major HDM
allergens, Der p 1 and Der p 2. Thus, Der p 23
represents a new major D. pteronyssinus
allergen. Furthermore, rDer p 23 exhibited
high allergenic activity… (test basofili)
2016n. 416n. 503
Batard T et al Allergy 2015
Sero-prevalence
Sero-dominance
Batard T et al Allergy 2015
2015
Serodominat allergens
2015
Sero-prevalence: ~ 40 of HDM sensitized
Sero-dominance: 10-15% of total binding when present
Mild tier allergens
Batard T et al Allergy 2015
Sero-prevalence
Sero-dominance
Batard T et al Allergy 2015
2015
5% in asthma
60% in AD
Dominant in
atopic dogs
High binding in
patient with active
scabies
Minor allergens
2015
Allergens of unknown importance
OUTLINE
1. Generalità sull’allergia agli acari
2. Le molecole allergeniche degli acari:
gerarchia e proprietà
3. Lo spreading molecolare della risposta IgE
agli acari
4.La diagnostica classica e molecolare
nell’allergia ad acari
5. Possibile ruolo predittivo del pattern
anticorpale
2017
prevalence
>40%
15-30%
<10%
time
A
94
AB
25
ABC
10
ABC
42
AB
39
A
4848 (51%)
26 (74%)
10 (100%)
AB
35
Figure 2
One or more of
Der p 1
Der p 2
Der p 23
One or more of
Der p 4
Der p 5
Der p 7
Der p 21
One or more of
Der p 11
Der p 14
Der p 15
Der p 18
Clone 16
One or more of
Der p 1
Der p 2
Der p 23
One or more of
Der p 1
Der p 2
Der p 23
+ +
One or more of
Der p 4
Der p 5
Der p 7
Der p 21
+
Molecularspreading
Posa D, et al. JACI 2017
Progressive IgE sensitization to D.pt. molecules of groups A, B, C
Some patients remain “blocked” at stage “A” of IgE sensitization
In others, the IgE molecular response spreads up to the level “ABC”
WHICH DETERMINANTS?
Earlier sensitization onset = stronger molecular spreading
Posa D, et al. JACI 2017
MORE
SPREADING
LESS
SPREADING
heredity AND environment affect
the spreading of the IgE response to mite allergen molecules
Posa D, et al. JACI 2017
OUTLINE
1. Generalità sull’allergia agli acari
2. Le molecole allergeniche degli acari:
gerarchia e proprietà
3. Lo spreading molecolare della risposta IgE
agli acari
4. La diagnostica classica e molecolare
nell’allergia ad acari
5. Possibile ruolo predittivo del pattern
anticorpale
Allergy 2010; 65: 184–190
Commercially available mite extracts
Values are expressed as μg protein/ml extract.
SPT
++
neg
++
neg
neg
neg
neg neg
neg
(cut-off < 7 mm2)
IAAI 2012
Casset A et ak Int Arch Allergy Immunol 2012
2016
Der p 1
Der p 2
OUTLINE
1. Generalità sull’allergia agli acari
2. Le molecole allergeniche degli acari:
gerarchia e proprietà
3. Lo spreading molecolare della risposta IgE
agli acari
4. La diagnostica classica e molecolare
nell’allergia ad acari
5. Possibile ruolo predittivo del pattern
anticorpale
2015
2015
OR
Der p 2 = 2.79
Der p 5 = 4.21
Der p 7 = 2.54
2017
AR (oct-jan)
Asthma
ABC
AB
A
neg
ABC
AB
A
neg
Population size
n=722
IgE response ≤ 5y of age % OR p-value OR p-value
Der p 1 sensitization 4.5 4.4 <0.001 3.0 0.031
Der p 2 sensitization 5.4 2.8 0.005 1.9 0.175
Der p 23 sensitization 2.8 4.3 0.002 5.3 0.009
Group "A" 6.9 4.0 <0.001 3.2 0.004
OR, Odds ratio
Dependent variable: at least 1 years with asthma between 6 and 20 years ofage in 709 children (binary variable),
in particular 580 observations for level 1 and 129 for level 2.
¹ Each line refers to an independent model, adjusted for hay fever parents, exposure, breast-feeding after one
month, mother smoking in pregnancy, older siblings, German nationality. Reference category is participants with
no IgEsensitization.
(1.3 - 5.5) (0.7 - 4.8)
(1.7 - 11.0) (1.5 - 19.5)
(2.1 - 7.5) (1.4 - 7.0)
(2.0 - 9.2) (1.1 - 8.2)
Table 5 - Association of an IgE response to group "A" D.pt. molecules (Der p 1, Der p 2, Der p 23) at
preschool age (≤5y) with the onset of asthma at school age (6-20y), in 709 participants of the MAS
birth cohort.
Univariate analysis Multivariable analysis¹
95% CI 95% CI
Der p 1 and Der p 23 at pre-school age
predict asthma at school age
Posa et al. JACI 2017
17 centri
519 soggetti SPT +
Sept 2019
TEST IN VITRO CON ESTRATTI DI ACARI
• Dosate IgE specifiche in 457 pazienti
• 23 (5%) sono risultati negativi sia per D1 che per D2.
• 411 (89,9%) sono risultati positivi per entrambi gli estratti.
• 16 (3,5%) monosensibili per D1
• 5 (1,1%) monosensibili per D2.
• Livello IgE specifiche 0,35-100 kU/L nei positivi.
• Livello medio IgE specifiche: D1= 22,5 kU/L; D2: 20,7 kU/L.
• La severità della rinite non correla con il livello delle IgE
specifiche.
• La presenza di asma correla significativamente con il titolo
di IgE specifiche (p< 0,0001 per D1 e D2).
Correlazione tra livello di IgE specifiche per
acari e presenza/severità di asma allergico
INDAGINI IN VITRO CON MOLECOLE
ALLERGENICHE
Prevalenze
• Positività per Der p 1: 58,6%
• Positività per Der p 2: 67,9%
• Positività per Der p 23: 59,8%
• Positività per Der p 10: 11,9%
67 (12,9%) NON SONO RISULTATI REATTIVI CON ALCUNA MOLECOLA.
17 (3,3%) MONOSENSIBILI A Der p 1
48 (9,3%) MONOSENSIBILI A Der p 2
42 (8,1%) MONOSENSIBILI A Der p 23
13 (2,5%) PAZIENTI SONO RISULTATI MONOSENSIBILI A Der p 10.
Allergeni maggiori
Influenza della polisensibilizzazione a molecole degli
acari sul livello di IgE specifiche per estratti
Il livello medio di IgE specifiche per estratto (D1) è
strettamente correlato al numero di molecole
riconosciute al paziente (p< 0,0001)
0
10
20
30
40
50
60
0 1 2 3 4
num molecole
Media RAST d1 kU/L
Significato clinico della
polisensibilizzazione ad allergeni di acari
Il rischio di asma bronchiale aumenta
con il numero di molecole a cui il
paziente è sensibilizzato.
La severità della sintomatologia
asmatica è in funzione del numero
di molecole a cui il paziente è
sensibile
0,00%
10,00%
20,00%
30,00%
40,00%
50,00%
60,00%
70,00%
0 1 2 3 4
num molecole
%ASMATICI
r: 0,844; p < 0.05
Prevalenza di sensibilizzazione alle
singole molecole in asmatici e non
Tutti i pazienti Monosensibili acari
La presenza di asma si associa con la
sensibilizzazione a Der p 2, Der p 10 e
Der p 23.
Nei pazienti monosensibili la presenza di
asma si associa con la sensibilizzazione al
solo Der p 23.
201911 - Villalta - Novità in ambito di diagnostica molecolare nella sensibilizzazione vs acari

More Related Content

What's hot

Immune tolerance
Immune toleranceImmune tolerance
Peanut allergy
Peanut allergyPeanut allergy
NSAIDs hypersensitivity - AERD
NSAIDs hypersensitivity - AERDNSAIDs hypersensitivity - AERD
Sesión Académica del CRAIC "Alergia alimentaria no mediada por IgE"
Sesión Académica del CRAIC "Alergia alimentaria no mediada por IgE"Sesión Académica del CRAIC "Alergia alimentaria no mediada por IgE"
Sesión Académica del CRAIC "Alergia alimentaria no mediada por IgE"
Sociedad Latinoamericana de Alergia, Asma e Inmunología
 
Hipersensibilidad a fármacos usados en la anestesia
Hipersensibilidad a fármacos usados en la anestesiaHipersensibilidad a fármacos usados en la anestesia
Hipersensibilidad a fármacos usados en la anestesia
Sociedad Latinoamericana de Alergia, Asma e Inmunología
 
Feb 2014 allergy b clinical and aqhi
Feb 2014 allergy b clinical and aqhiFeb 2014 allergy b clinical and aqhi
Feb 2014 allergy b clinical and aqhiIhsaan Peer
 
Adverse reactions to vaccines practice parameter 2012 update
Adverse reactions to vaccines practice parameter 2012 updateAdverse reactions to vaccines practice parameter 2012 update
Adverse reactions to vaccines practice parameter 2012 update
Chulalongkorn Allergy and Clinical Immunology Research Group
 
2013 april
2013 april2013 april
2013 april
Juan Aldave
 
Drug induced Anaphylaxis in Latin America
Drug induced Anaphylaxis in Latin AmericaDrug induced Anaphylaxis in Latin America
Drug induced Anaphylaxis in Latin America
Juan Carlos Ivancevich
 
Arzu didem yalcin, MD. kiev. Allergy Congres
Arzu didem yalcin, MD. kiev. Allergy CongresArzu didem yalcin, MD. kiev. Allergy Congres
Arzu didem yalcin, MD. kiev. Allergy Congres
American Academy of Allergy, Asthma and Immunology - AAAAI
 
20171111 - Martelli - L’allergia non IgE mediata al latte vaccino
20171111 - Martelli - L’allergia non IgE mediata al latte vaccino20171111 - Martelli - L’allergia non IgE mediata al latte vaccino
20171111 - Martelli - L’allergia non IgE mediata al latte vaccino
Asmallergie
 
Uso de esteroides nasales en el tratamiento de pacientes con rinitis alérgica...
Uso de esteroides nasales en el tratamiento de pacientes con rinitis alérgica...Uso de esteroides nasales en el tratamiento de pacientes con rinitis alérgica...
Uso de esteroides nasales en el tratamiento de pacientes con rinitis alérgica...
Sociedad Latinoamericana de Alergia, Asma e Inmunología
 
20171111- Pingitore - Microbioma e malattie allergiche
20171111- Pingitore - Microbioma e malattie allergiche20171111- Pingitore - Microbioma e malattie allergiche
20171111- Pingitore - Microbioma e malattie allergiche
Asmallergie
 
L. P. Boulet - The Late Asthmatic Response
L. P. Boulet - The Late Asthmatic ResponseL. P. Boulet - The Late Asthmatic Response
L. P. Boulet - The Late Asthmatic Response
Juan Carlos Ivancevich
 
Dennis’s Chronic Sinusitis Article
Dennis’s Chronic Sinusitis ArticleDennis’s Chronic Sinusitis Article
Dennis’s Chronic Sinusitis Article
jaclynross2612
 
2013 July - Pearls in Allergy and Immunology
2013 July - Pearls in Allergy and Immunology2013 July - Pearls in Allergy and Immunology
2013 July - Pearls in Allergy and ImmunologyJuan Aldave
 
Patient characteristics and IVIG may affect eosinophil in Kawasaki disease
Patient characteristics and IVIG may affect eosinophil in Kawasaki diseasePatient characteristics and IVIG may affect eosinophil in Kawasaki disease
Patient characteristics and IVIG may affect eosinophil in Kawasaki disease
guest7872cde
 
2013 june Pearls in Allergy and Clinical Immunology
2013 june Pearls in Allergy and Clinical Immunology2013 june Pearls in Allergy and Clinical Immunology
2013 june Pearls in Allergy and Clinical ImmunologyJuan Aldave
 

What's hot (20)

Diagnosis atopy
Diagnosis atopyDiagnosis atopy
Diagnosis atopy
 
Immune tolerance
Immune toleranceImmune tolerance
Immune tolerance
 
Peanut allergy
Peanut allergyPeanut allergy
Peanut allergy
 
NSAIDs hypersensitivity - AERD
NSAIDs hypersensitivity - AERDNSAIDs hypersensitivity - AERD
NSAIDs hypersensitivity - AERD
 
Sesión Académica del CRAIC "Alergia alimentaria no mediada por IgE"
Sesión Académica del CRAIC "Alergia alimentaria no mediada por IgE"Sesión Académica del CRAIC "Alergia alimentaria no mediada por IgE"
Sesión Académica del CRAIC "Alergia alimentaria no mediada por IgE"
 
Hipersensibilidad a fármacos usados en la anestesia
Hipersensibilidad a fármacos usados en la anestesiaHipersensibilidad a fármacos usados en la anestesia
Hipersensibilidad a fármacos usados en la anestesia
 
Feb 2014 allergy b clinical and aqhi
Feb 2014 allergy b clinical and aqhiFeb 2014 allergy b clinical and aqhi
Feb 2014 allergy b clinical and aqhi
 
Adverse reactions to vaccines practice parameter 2012 update
Adverse reactions to vaccines practice parameter 2012 updateAdverse reactions to vaccines practice parameter 2012 update
Adverse reactions to vaccines practice parameter 2012 update
 
2013 april
2013 april2013 april
2013 april
 
Drug induced Anaphylaxis in Latin America
Drug induced Anaphylaxis in Latin AmericaDrug induced Anaphylaxis in Latin America
Drug induced Anaphylaxis in Latin America
 
Arzu didem yalcin, MD. kiev. Allergy Congres
Arzu didem yalcin, MD. kiev. Allergy CongresArzu didem yalcin, MD. kiev. Allergy Congres
Arzu didem yalcin, MD. kiev. Allergy Congres
 
20171111 - Martelli - L’allergia non IgE mediata al latte vaccino
20171111 - Martelli - L’allergia non IgE mediata al latte vaccino20171111 - Martelli - L’allergia non IgE mediata al latte vaccino
20171111 - Martelli - L’allergia non IgE mediata al latte vaccino
 
Uso de esteroides nasales en el tratamiento de pacientes con rinitis alérgica...
Uso de esteroides nasales en el tratamiento de pacientes con rinitis alérgica...Uso de esteroides nasales en el tratamiento de pacientes con rinitis alérgica...
Uso de esteroides nasales en el tratamiento de pacientes con rinitis alérgica...
 
20171111- Pingitore - Microbioma e malattie allergiche
20171111- Pingitore - Microbioma e malattie allergiche20171111- Pingitore - Microbioma e malattie allergiche
20171111- Pingitore - Microbioma e malattie allergiche
 
L. P. Boulet - The Late Asthmatic Response
L. P. Boulet - The Late Asthmatic ResponseL. P. Boulet - The Late Asthmatic Response
L. P. Boulet - The Late Asthmatic Response
 
Dennis’s Chronic Sinusitis Article
Dennis’s Chronic Sinusitis ArticleDennis’s Chronic Sinusitis Article
Dennis’s Chronic Sinusitis Article
 
2013 July - Pearls in Allergy and Immunology
2013 July - Pearls in Allergy and Immunology2013 July - Pearls in Allergy and Immunology
2013 July - Pearls in Allergy and Immunology
 
Patient characteristics and IVIG may affect eosinophil in Kawasaki disease
Patient characteristics and IVIG may affect eosinophil in Kawasaki diseasePatient characteristics and IVIG may affect eosinophil in Kawasaki disease
Patient characteristics and IVIG may affect eosinophil in Kawasaki disease
 
2013 june Pearls in Allergy and Clinical Immunology
2013 june Pearls in Allergy and Clinical Immunology2013 june Pearls in Allergy and Clinical Immunology
2013 june Pearls in Allergy and Clinical Immunology
 
epicutaneous immunotherapy
epicutaneous immunotherapyepicutaneous immunotherapy
epicutaneous immunotherapy
 

Similar to 201911 - Villalta - Novità in ambito di diagnostica molecolare nella sensibilizzazione vs acari

Insect sting allergy
Insect sting allergyInsect sting allergy
Allergy- Laboratory Diagnostic Tests
Allergy- Laboratory Diagnostic TestsAllergy- Laboratory Diagnostic Tests
Allergy- Laboratory Diagnostic Tests
Dr. Rajesh Bendre
 
&lt;마더세이프라운드> 소아알레르기 예방
&lt;마더세이프라운드> 소아알레르기 예방&lt;마더세이프라운드> 소아알레르기 예방
&lt;마더세이프라운드> 소아알레르기 예방
mothersafe
 
Food immunotherapy.pdf
Food immunotherapy.pdfFood immunotherapy.pdf
Explore the cell's role in mediating adverse reactions 7 c09
Explore the cell's role in mediating adverse reactions 7 c09Explore the cell's role in mediating adverse reactions 7 c09
Explore the cell's role in mediating adverse reactions 7 c09
Paul Thiessen
 
Src jbbr-21-125 Dr. ihsan edan abdulkareem alsaimary PROFESSOR IN MEDICAL M...
Src jbbr-21-125  Dr. ihsan edan abdulkareem alsaimary  PROFESSOR IN MEDICAL M...Src jbbr-21-125  Dr. ihsan edan abdulkareem alsaimary  PROFESSOR IN MEDICAL M...
Src jbbr-21-125 Dr. ihsan edan abdulkareem alsaimary PROFESSOR IN MEDICAL M...
dr.Ihsan alsaimary
 
Peanut allergy.pdf
Peanut allergy.pdfPeanut allergy.pdf
Antibiotic hypersensitivity.pdf
Antibiotic hypersensitivity.pdfAntibiotic hypersensitivity.pdf
Tree Nut Allergy.pdf
Tree Nut Allergy.pdfTree Nut Allergy.pdf
Egg allergy: new allergens and molecular diagnosis
Egg allergy: new allergens and molecular diagnosisEgg allergy: new allergens and molecular diagnosis
Egg allergy: new allergens and molecular diagnosis
Chulalongkorn Allergy and Clinical Immunology Research Group
 
What diagnosis atopy
What diagnosis atopyWhat diagnosis atopy
What diagnosis atopy
Envicon Medical Srl
 
AD.pptx
AD.pptxAD.pptx
Research Project Poster FINAL
Research Project Poster FINALResearch Project Poster FINAL
Research Project Poster FINALRebecca Coxhill
 
Format 2015: what is new in pediatric allergic diseases
Format 2015: what is new in pediatric allergic diseasesFormat 2015: what is new in pediatric allergic diseases
Format 2015: what is new in pediatric allergic diseases
Envicon Medical Srl
 
Atopic dermatitis
Atopic dermatitisAtopic dermatitis
Explore the cell's role in mediating adverse reactions
Explore the cell's role in mediating adverse reactionsExplore the cell's role in mediating adverse reactions
Explore the cell's role in mediating adverse reactions
Cell Science Systems
 
Cephalosporin use on Penicillin Allergy patients
Cephalosporin use on Penicillin Allergy patientsCephalosporin use on Penicillin Allergy patients
Cephalosporin use on Penicillin Allergy patients
rishad_87
 
Allergy march from atopic dermatitis to lifelong allergy
Allergy march from atopic dermatitis to lifelong allergyAllergy march from atopic dermatitis to lifelong allergy
Allergy march from atopic dermatitis to lifelong allergy
Ariyanto Harsono
 

Similar to 201911 - Villalta - Novità in ambito di diagnostica molecolare nella sensibilizzazione vs acari (20)

Insect sting allergy
Insect sting allergyInsect sting allergy
Insect sting allergy
 
Allergy- Laboratory Diagnostic Tests
Allergy- Laboratory Diagnostic TestsAllergy- Laboratory Diagnostic Tests
Allergy- Laboratory Diagnostic Tests
 
&lt;마더세이프라운드> 소아알레르기 예방
&lt;마더세이프라운드> 소아알레르기 예방&lt;마더세이프라운드> 소아알레르기 예방
&lt;마더세이프라운드> 소아알레르기 예방
 
Food immunotherapy.pdf
Food immunotherapy.pdfFood immunotherapy.pdf
Food immunotherapy.pdf
 
Explore the cell's role in mediating adverse reactions 7 c09
Explore the cell's role in mediating adverse reactions 7 c09Explore the cell's role in mediating adverse reactions 7 c09
Explore the cell's role in mediating adverse reactions 7 c09
 
Peanut Allergy 2009
Peanut Allergy 2009Peanut Allergy 2009
Peanut Allergy 2009
 
Src jbbr-21-125 Dr. ihsan edan abdulkareem alsaimary PROFESSOR IN MEDICAL M...
Src jbbr-21-125  Dr. ihsan edan abdulkareem alsaimary  PROFESSOR IN MEDICAL M...Src jbbr-21-125  Dr. ihsan edan abdulkareem alsaimary  PROFESSOR IN MEDICAL M...
Src jbbr-21-125 Dr. ihsan edan abdulkareem alsaimary PROFESSOR IN MEDICAL M...
 
Peanut allergy.pdf
Peanut allergy.pdfPeanut allergy.pdf
Peanut allergy.pdf
 
Antibiotic hypersensitivity.pdf
Antibiotic hypersensitivity.pdfAntibiotic hypersensitivity.pdf
Antibiotic hypersensitivity.pdf
 
Tree Nut Allergy.pdf
Tree Nut Allergy.pdfTree Nut Allergy.pdf
Tree Nut Allergy.pdf
 
Egg allergy: new allergens and molecular diagnosis
Egg allergy: new allergens and molecular diagnosisEgg allergy: new allergens and molecular diagnosis
Egg allergy: new allergens and molecular diagnosis
 
What diagnosis atopy
What diagnosis atopyWhat diagnosis atopy
What diagnosis atopy
 
AD.pptx
AD.pptxAD.pptx
AD.pptx
 
Research Project Poster FINAL
Research Project Poster FINALResearch Project Poster FINAL
Research Project Poster FINAL
 
Format 2015: what is new in pediatric allergic diseases
Format 2015: what is new in pediatric allergic diseasesFormat 2015: what is new in pediatric allergic diseases
Format 2015: what is new in pediatric allergic diseases
 
Atopic dermatitis
Atopic dermatitisAtopic dermatitis
Atopic dermatitis
 
What 2012 immunotherapy
What 2012 immunotherapyWhat 2012 immunotherapy
What 2012 immunotherapy
 
Explore the cell's role in mediating adverse reactions
Explore the cell's role in mediating adverse reactionsExplore the cell's role in mediating adverse reactions
Explore the cell's role in mediating adverse reactions
 
Cephalosporin use on Penicillin Allergy patients
Cephalosporin use on Penicillin Allergy patientsCephalosporin use on Penicillin Allergy patients
Cephalosporin use on Penicillin Allergy patients
 
Allergy march from atopic dermatitis to lifelong allergy
Allergy march from atopic dermatitis to lifelong allergyAllergy march from atopic dermatitis to lifelong allergy
Allergy march from atopic dermatitis to lifelong allergy
 

More from Asmallergie

201911 - Tripodi - Immunoterapia specifica alla luce della e-mobile health?
201911 - Tripodi - Immunoterapia specifica alla luce della e-mobile health?201911 - Tripodi - Immunoterapia specifica alla luce della e-mobile health?
201911 - Tripodi - Immunoterapia specifica alla luce della e-mobile health?
Asmallergie
 
201911 - Calvani - L’orticaria
201911 - Calvani - L’orticaria201911 - Calvani - L’orticaria
201911 - Calvani - L’orticaria
Asmallergie
 
201911 - Scala - Gli antiossidanti
201911 - Scala - Gli antiossidanti201911 - Scala - Gli antiossidanti
201911 - Scala - Gli antiossidanti
Asmallergie
 
201911 - Pingitore - Quando usare i probiotici in pediatria?
201911 - Pingitore - Quando usare i probiotici in pediatria?201911 - Pingitore - Quando usare i probiotici in pediatria?
201911 - Pingitore - Quando usare i probiotici in pediatria?
Asmallergie
 
201911 - Solidoro - Ambiti di utilizzo della “triplice”
201911 - Solidoro - Ambiti di utilizzo della “triplice”201911 - Solidoro - Ambiti di utilizzo della “triplice”
201911 - Solidoro - Ambiti di utilizzo della “triplice”
Asmallergie
 
201911 - Polla - Il valore aggiunto delle prove di funzionalità respiratoria
201911 - Polla - Il valore aggiunto delle prove di funzionalità respiratoria201911 - Polla - Il valore aggiunto delle prove di funzionalità respiratoria
201911 - Polla - Il valore aggiunto delle prove di funzionalità respiratoria
Asmallergie
 
201911 - Omodeo - Significato e ambiti di utilizzo del FeNO (ossido nitrico e...
201911 - Omodeo - Significato e ambiti di utilizzo del FeNO (ossido nitrico e...201911 - Omodeo - Significato e ambiti di utilizzo del FeNO (ossido nitrico e...
201911 - Omodeo - Significato e ambiti di utilizzo del FeNO (ossido nitrico e...
Asmallergie
 
201911 - Rossi - L'asma grave è sempre “grave”?
201911 - Rossi - L'asma grave è sempre “grave”?201911 - Rossi - L'asma grave è sempre “grave”?
201911 - Rossi - L'asma grave è sempre “grave”?
Asmallergie
 
201911 - Piccioni - Integrazione terapeutica pneumologica
201911 - Piccioni - Integrazione terapeutica pneumologica201911 - Piccioni - Integrazione terapeutica pneumologica
201911 - Piccioni - Integrazione terapeutica pneumologica
Asmallergie
 
201911 - Pecorari - ORL: quando la terapia chirurgica
201911 - Pecorari - ORL: quando la terapia chirurgica201911 - Pecorari - ORL: quando la terapia chirurgica
201911 - Pecorari - ORL: quando la terapia chirurgica
Asmallergie
 
201911 - Garzaro - ORL: quando la terapia medica
201911 - Garzaro - ORL: quando la terapia medica201911 - Garzaro - ORL: quando la terapia medica
201911 - Garzaro - ORL: quando la terapia medica
Asmallergie
 
201911 - Del Giudice -Il ruolo dell’allergia nella Sindrome Infiammatoria rin...
201911 - Del Giudice -Il ruolo dell’allergia nella Sindrome Infiammatoria rin...201911 - Del Giudice -Il ruolo dell’allergia nella Sindrome Infiammatoria rin...
201911 - Del Giudice -Il ruolo dell’allergia nella Sindrome Infiammatoria rin...
Asmallergie
 
201911 - Mangiapia - La patologia pneumologica nella sindrome rinobronchiale
201911 - Mangiapia - La patologia pneumologica nella sindrome rinobronchiale201911 - Mangiapia - La patologia pneumologica nella sindrome rinobronchiale
201911 - Mangiapia - La patologia pneumologica nella sindrome rinobronchiale
Asmallergie
 
201911 - Ferrero - La patologia ORL nella sindrome rinobronchiale
201911 - Ferrero - La patologia ORL nella sindrome rinobronchiale201911 - Ferrero - La patologia ORL nella sindrome rinobronchiale
201911 - Ferrero - La patologia ORL nella sindrome rinobronchiale
Asmallergie
 
201911 - Ortoncelli - Dupilumab nella DA: attuali esperienze
201911 - Ortoncelli - Dupilumab nella DA: attuali esperienze201911 - Ortoncelli - Dupilumab nella DA: attuali esperienze
201911 - Ortoncelli - Dupilumab nella DA: attuali esperienze
Asmallergie
 
201911 - Conte - Asma eosinofilico: i farmaci biologici che contrastano l'azi...
201911 - Conte - Asma eosinofilico: i farmaci biologici che contrastano l'azi...201911 - Conte - Asma eosinofilico: i farmaci biologici che contrastano l'azi...
201911 - Conte - Asma eosinofilico: i farmaci biologici che contrastano l'azi...
Asmallergie
 
201911 - Frati - Cosa preferisce il paziente nella scelta dell'immunoterapia?
201911 - Frati - Cosa preferisce il paziente nella scelta dell'immunoterapia?201911 - Frati - Cosa preferisce il paziente nella scelta dell'immunoterapia?
201911 - Frati - Cosa preferisce il paziente nella scelta dell'immunoterapia?
Asmallergie
 
201911 - Burastero - Immunoterapia specifica nell’asma bronchiale allergica
201911 - Burastero - Immunoterapia specifica nell’asma bronchiale allergica201911 - Burastero - Immunoterapia specifica nell’asma bronchiale allergica
201911 - Burastero - Immunoterapia specifica nell’asma bronchiale allergica
Asmallergie
 
20191109 - Incorvaia - L'efficacia della SLIT: dai trial alla real-life
20191109 - Incorvaia - L'efficacia della SLIT: dai trial alla real-life20191109 - Incorvaia - L'efficacia della SLIT: dai trial alla real-life
20191109 - Incorvaia - L'efficacia della SLIT: dai trial alla real-life
Asmallergie
 
20181110 - Audisio di Somma - Allergia e l'altra medicina
20181110 - Audisio di Somma - Allergia e l'altra medicina20181110 - Audisio di Somma - Allergia e l'altra medicina
20181110 - Audisio di Somma - Allergia e l'altra medicina
Asmallergie
 

More from Asmallergie (20)

201911 - Tripodi - Immunoterapia specifica alla luce della e-mobile health?
201911 - Tripodi - Immunoterapia specifica alla luce della e-mobile health?201911 - Tripodi - Immunoterapia specifica alla luce della e-mobile health?
201911 - Tripodi - Immunoterapia specifica alla luce della e-mobile health?
 
201911 - Calvani - L’orticaria
201911 - Calvani - L’orticaria201911 - Calvani - L’orticaria
201911 - Calvani - L’orticaria
 
201911 - Scala - Gli antiossidanti
201911 - Scala - Gli antiossidanti201911 - Scala - Gli antiossidanti
201911 - Scala - Gli antiossidanti
 
201911 - Pingitore - Quando usare i probiotici in pediatria?
201911 - Pingitore - Quando usare i probiotici in pediatria?201911 - Pingitore - Quando usare i probiotici in pediatria?
201911 - Pingitore - Quando usare i probiotici in pediatria?
 
201911 - Solidoro - Ambiti di utilizzo della “triplice”
201911 - Solidoro - Ambiti di utilizzo della “triplice”201911 - Solidoro - Ambiti di utilizzo della “triplice”
201911 - Solidoro - Ambiti di utilizzo della “triplice”
 
201911 - Polla - Il valore aggiunto delle prove di funzionalità respiratoria
201911 - Polla - Il valore aggiunto delle prove di funzionalità respiratoria201911 - Polla - Il valore aggiunto delle prove di funzionalità respiratoria
201911 - Polla - Il valore aggiunto delle prove di funzionalità respiratoria
 
201911 - Omodeo - Significato e ambiti di utilizzo del FeNO (ossido nitrico e...
201911 - Omodeo - Significato e ambiti di utilizzo del FeNO (ossido nitrico e...201911 - Omodeo - Significato e ambiti di utilizzo del FeNO (ossido nitrico e...
201911 - Omodeo - Significato e ambiti di utilizzo del FeNO (ossido nitrico e...
 
201911 - Rossi - L'asma grave è sempre “grave”?
201911 - Rossi - L'asma grave è sempre “grave”?201911 - Rossi - L'asma grave è sempre “grave”?
201911 - Rossi - L'asma grave è sempre “grave”?
 
201911 - Piccioni - Integrazione terapeutica pneumologica
201911 - Piccioni - Integrazione terapeutica pneumologica201911 - Piccioni - Integrazione terapeutica pneumologica
201911 - Piccioni - Integrazione terapeutica pneumologica
 
201911 - Pecorari - ORL: quando la terapia chirurgica
201911 - Pecorari - ORL: quando la terapia chirurgica201911 - Pecorari - ORL: quando la terapia chirurgica
201911 - Pecorari - ORL: quando la terapia chirurgica
 
201911 - Garzaro - ORL: quando la terapia medica
201911 - Garzaro - ORL: quando la terapia medica201911 - Garzaro - ORL: quando la terapia medica
201911 - Garzaro - ORL: quando la terapia medica
 
201911 - Del Giudice -Il ruolo dell’allergia nella Sindrome Infiammatoria rin...
201911 - Del Giudice -Il ruolo dell’allergia nella Sindrome Infiammatoria rin...201911 - Del Giudice -Il ruolo dell’allergia nella Sindrome Infiammatoria rin...
201911 - Del Giudice -Il ruolo dell’allergia nella Sindrome Infiammatoria rin...
 
201911 - Mangiapia - La patologia pneumologica nella sindrome rinobronchiale
201911 - Mangiapia - La patologia pneumologica nella sindrome rinobronchiale201911 - Mangiapia - La patologia pneumologica nella sindrome rinobronchiale
201911 - Mangiapia - La patologia pneumologica nella sindrome rinobronchiale
 
201911 - Ferrero - La patologia ORL nella sindrome rinobronchiale
201911 - Ferrero - La patologia ORL nella sindrome rinobronchiale201911 - Ferrero - La patologia ORL nella sindrome rinobronchiale
201911 - Ferrero - La patologia ORL nella sindrome rinobronchiale
 
201911 - Ortoncelli - Dupilumab nella DA: attuali esperienze
201911 - Ortoncelli - Dupilumab nella DA: attuali esperienze201911 - Ortoncelli - Dupilumab nella DA: attuali esperienze
201911 - Ortoncelli - Dupilumab nella DA: attuali esperienze
 
201911 - Conte - Asma eosinofilico: i farmaci biologici che contrastano l'azi...
201911 - Conte - Asma eosinofilico: i farmaci biologici che contrastano l'azi...201911 - Conte - Asma eosinofilico: i farmaci biologici che contrastano l'azi...
201911 - Conte - Asma eosinofilico: i farmaci biologici che contrastano l'azi...
 
201911 - Frati - Cosa preferisce il paziente nella scelta dell'immunoterapia?
201911 - Frati - Cosa preferisce il paziente nella scelta dell'immunoterapia?201911 - Frati - Cosa preferisce il paziente nella scelta dell'immunoterapia?
201911 - Frati - Cosa preferisce il paziente nella scelta dell'immunoterapia?
 
201911 - Burastero - Immunoterapia specifica nell’asma bronchiale allergica
201911 - Burastero - Immunoterapia specifica nell’asma bronchiale allergica201911 - Burastero - Immunoterapia specifica nell’asma bronchiale allergica
201911 - Burastero - Immunoterapia specifica nell’asma bronchiale allergica
 
20191109 - Incorvaia - L'efficacia della SLIT: dai trial alla real-life
20191109 - Incorvaia - L'efficacia della SLIT: dai trial alla real-life20191109 - Incorvaia - L'efficacia della SLIT: dai trial alla real-life
20191109 - Incorvaia - L'efficacia della SLIT: dai trial alla real-life
 
20181110 - Audisio di Somma - Allergia e l'altra medicina
20181110 - Audisio di Somma - Allergia e l'altra medicina20181110 - Audisio di Somma - Allergia e l'altra medicina
20181110 - Audisio di Somma - Allergia e l'altra medicina
 

Recently uploaded

KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
Little Cross Family Clinic
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Dr KHALID B.M
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyayaCharaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Dr KHALID B.M
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
Jim Jacob Roy
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Savita Shen $i11
 
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in StockFactory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
rebeccabio
 
THOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation ActTHOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation Act
DrSathishMS1
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
SumeraAhmad5
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
Levi Shapiro
 

Recently uploaded (20)

KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyayaCharaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
 
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in StockFactory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
 
THOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation ActTHOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation Act
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 

201911 - Villalta - Novità in ambito di diagnostica molecolare nella sensibilizzazione vs acari

  • 1. Novità in ambito di diagnostica molecolare nella sensibilizzazione ad acari Danilo Villalta Immunologia e Allergologia Ospedale «S. Maria degli Angeli» Pordenone
  • 2. OUTLINE 1. Note storiche e generalità sull’allergia agli acari 2. Le molecole allergeniche degli acari: gerarchia e proprietà 3. Lo spreading molecolare della risposta IgE agli acari 4. La diagnostica classica e molecolare nell’allergia ad acari 5. Possibile ruolo predittivo del pattern anticorpale
  • 3. OUTLINE 1. Note storiche e generalità sull’allergia agli acari 2. Le molecole allergeniche degli acari: gerarchia e proprietà 3. Lo spreading molecolare della risposta IgE agli acari 4. La diagnostica classica e molecolare nell’allergia ad acari 5. Possibile ruolo predittivo del pattern anticorpale
  • 4. Historical milestones - As early as 1921 Kern RA reported that many asthmatics had strongly positive skin test to house dust (Med Clin North Am 1921) - In 1928 dr Dekker suggested that mites played an important role in allergy, but this evidence was unconvincing (Munch Med Wochenschr 1928) - In 1964 Woorhorst et al. identified Dermatophagoides pteronissinus as house dust allergen (J Allergy 1967) - In 1968 Brown described the first extract for dignostic skin test (Br Med J 1968) - In 1971 extracts were available for immunotherapy (Smith AP. Br Med J 1971) - In 1980 the first allergen of Dermatofagoides pteronissinus was described by Chapman & Platts-Mills (J Immunol 1980) - In 2013 was identified the molecular structure of the new major HDM allergen, Der p 23 (Weghofer M, J Immunol 2013)
  • 5. - The normal life span of a HDMs is approximately 65-100 days - Proliferate maximally at a relative umidity of 75% - Complete the egg-to-adulte cycle in 35 days at 23°C, but in only half time at 30°C - Females lay approximately 50-80 eggs during their lifetime - Each immature mite stage need to shed its exoskeleton before passing onto the next stage
  • 6. - During their lifetime mites produce approximately 1000 solid fecal waste particle (about 25 μ in diameter) surrounded by a peritrophic membrane containing proteolytic digestive enzymes
  • 7. OUTLINE 1. Generalità sull’allergia agli acari 2. Le molecole allergeniche degli acari: gerarchia e proprietà 3. Lo spreading molecolare della risposta IgE agli acari 4. La diagnostica classica e molecolare nell’allergia ad acari 5. Possibile ruolo predittivo del pattern anticorpale
  • 8.
  • 9. Schematic and still debated localization of the 12 examined allergenic molecules of Dermatophagoides pteronyssinus. 1 15 18 11 21 14 23 7 5 4 2 1 22 Adapted and extended from Weghofer M. J Immunol. 2013; 190:3059-67. Banerjee S. J Invest Dermatol. 2015; 135:102-9. Thomas WR. Allergol Int 2015; 64:304-11 Thomas WR. Chang Gung Med J. 2004; 27:563-9. O'Neil SE. Clin Exp Allergy. 2006; 36:831-9. Courtesy of P. Matricardi
  • 10. Reithofer M & Jahn-Schmid B. Int J Mol Sci 2017.18,1368
  • 11. Group 2 MD-2 like lipid binding protein TSAI JJ PLOS 2011 «auto-adjuvant» properties
  • 12. Miller JD. Clin Rev Allergy Immunol 2018, June 23
  • 13. The «classical» mite molecules Cysteinprotease Der p 1 Der p 2 Lipid binding protein Der p 10 Tropomyosin
  • 14. Trombone APF et al CEA 2001;32:1323-8 - 95% HDM positive - Accounting for 60% of antibodies
  • 15. J Immunol. 2013 April 1; 190(7): 3059–3067 Chitin-binding protein
  • 16. Der p 23 is a protein of the peritrophic matrix that lines the midgut and surrounds the digested food stuff and the fecal pellets. In mites, as in most Arthropods, fecal pellets are surrounded by the peritrophic matrix. The peritrophic matrix is synthesized along the whole midgut of the HDMs and functions as a permeability barrier between the ingested food and midgut epithelium. It enhances digestive processes and protects the midgut epithelium from mechanical disruption as well as from attacks by toxins and pathogens. The peritrophic matrix is thought to be secreted by the microvilli of gut epithelial cells and is composed of a meshwork of chitin fibrils embedded in a matrix of proteins, proteoglycans, and glycoproteins. In fact, the in situ localization suggests that Der p 23 is indeed synthesized in the midgut epithelial cells where the allergen is localized in vesicles.
  • 17. It reacted with IgE Abs from 74% of D. pteronyssinus allergic patients (n = 347) at levels comparable to the two major HDM allergens, Der p 1 and Der p 2. Thus, Der p 23 represents a new major D. pteronyssinus allergen. Furthermore, rDer p 23 exhibited high allergenic activity… (test basofili)
  • 19. Batard T et al Allergy 2015 Sero-prevalence
  • 20. Sero-dominance Batard T et al Allergy 2015
  • 22. 2015 Sero-prevalence: ~ 40 of HDM sensitized Sero-dominance: 10-15% of total binding when present Mild tier allergens
  • 23. Batard T et al Allergy 2015 Sero-prevalence
  • 24. Sero-dominance Batard T et al Allergy 2015
  • 25. 2015 5% in asthma 60% in AD Dominant in atopic dogs High binding in patient with active scabies Minor allergens
  • 27. OUTLINE 1. Generalità sull’allergia agli acari 2. Le molecole allergeniche degli acari: gerarchia e proprietà 3. Lo spreading molecolare della risposta IgE agli acari 4.La diagnostica classica e molecolare nell’allergia ad acari 5. Possibile ruolo predittivo del pattern anticorpale
  • 29. time A 94 AB 25 ABC 10 ABC 42 AB 39 A 4848 (51%) 26 (74%) 10 (100%) AB 35 Figure 2 One or more of Der p 1 Der p 2 Der p 23 One or more of Der p 4 Der p 5 Der p 7 Der p 21 One or more of Der p 11 Der p 14 Der p 15 Der p 18 Clone 16 One or more of Der p 1 Der p 2 Der p 23 One or more of Der p 1 Der p 2 Der p 23 + + One or more of Der p 4 Der p 5 Der p 7 Der p 21 + Molecularspreading Posa D, et al. JACI 2017 Progressive IgE sensitization to D.pt. molecules of groups A, B, C
  • 30. Some patients remain “blocked” at stage “A” of IgE sensitization In others, the IgE molecular response spreads up to the level “ABC” WHICH DETERMINANTS?
  • 31. Earlier sensitization onset = stronger molecular spreading Posa D, et al. JACI 2017 MORE SPREADING LESS SPREADING
  • 32. heredity AND environment affect the spreading of the IgE response to mite allergen molecules Posa D, et al. JACI 2017
  • 33. OUTLINE 1. Generalità sull’allergia agli acari 2. Le molecole allergeniche degli acari: gerarchia e proprietà 3. Lo spreading molecolare della risposta IgE agli acari 4. La diagnostica classica e molecolare nell’allergia ad acari 5. Possibile ruolo predittivo del pattern anticorpale
  • 34. Allergy 2010; 65: 184–190 Commercially available mite extracts
  • 35. Values are expressed as μg protein/ml extract. SPT ++ neg ++ neg neg neg neg neg neg (cut-off < 7 mm2)
  • 37. Casset A et ak Int Arch Allergy Immunol 2012
  • 38. 2016
  • 41.
  • 42. OUTLINE 1. Generalità sull’allergia agli acari 2. Le molecole allergeniche degli acari: gerarchia e proprietà 3. Lo spreading molecolare della risposta IgE agli acari 4. La diagnostica classica e molecolare nell’allergia ad acari 5. Possibile ruolo predittivo del pattern anticorpale
  • 43. 2015
  • 44. 2015 OR Der p 2 = 2.79 Der p 5 = 4.21 Der p 7 = 2.54
  • 46. IgE response ≤ 5y of age % OR p-value OR p-value Der p 1 sensitization 4.5 4.4 <0.001 3.0 0.031 Der p 2 sensitization 5.4 2.8 0.005 1.9 0.175 Der p 23 sensitization 2.8 4.3 0.002 5.3 0.009 Group "A" 6.9 4.0 <0.001 3.2 0.004 OR, Odds ratio Dependent variable: at least 1 years with asthma between 6 and 20 years ofage in 709 children (binary variable), in particular 580 observations for level 1 and 129 for level 2. ¹ Each line refers to an independent model, adjusted for hay fever parents, exposure, breast-feeding after one month, mother smoking in pregnancy, older siblings, German nationality. Reference category is participants with no IgEsensitization. (1.3 - 5.5) (0.7 - 4.8) (1.7 - 11.0) (1.5 - 19.5) (2.1 - 7.5) (1.4 - 7.0) (2.0 - 9.2) (1.1 - 8.2) Table 5 - Association of an IgE response to group "A" D.pt. molecules (Der p 1, Der p 2, Der p 23) at preschool age (≤5y) with the onset of asthma at school age (6-20y), in 709 participants of the MAS birth cohort. Univariate analysis Multivariable analysis¹ 95% CI 95% CI Der p 1 and Der p 23 at pre-school age predict asthma at school age Posa et al. JACI 2017
  • 47. 17 centri 519 soggetti SPT + Sept 2019
  • 48. TEST IN VITRO CON ESTRATTI DI ACARI • Dosate IgE specifiche in 457 pazienti • 23 (5%) sono risultati negativi sia per D1 che per D2. • 411 (89,9%) sono risultati positivi per entrambi gli estratti. • 16 (3,5%) monosensibili per D1 • 5 (1,1%) monosensibili per D2. • Livello IgE specifiche 0,35-100 kU/L nei positivi. • Livello medio IgE specifiche: D1= 22,5 kU/L; D2: 20,7 kU/L. • La severità della rinite non correla con il livello delle IgE specifiche. • La presenza di asma correla significativamente con il titolo di IgE specifiche (p< 0,0001 per D1 e D2).
  • 49. Correlazione tra livello di IgE specifiche per acari e presenza/severità di asma allergico
  • 50. INDAGINI IN VITRO CON MOLECOLE ALLERGENICHE
  • 51. Prevalenze • Positività per Der p 1: 58,6% • Positività per Der p 2: 67,9% • Positività per Der p 23: 59,8% • Positività per Der p 10: 11,9% 67 (12,9%) NON SONO RISULTATI REATTIVI CON ALCUNA MOLECOLA. 17 (3,3%) MONOSENSIBILI A Der p 1 48 (9,3%) MONOSENSIBILI A Der p 2 42 (8,1%) MONOSENSIBILI A Der p 23 13 (2,5%) PAZIENTI SONO RISULTATI MONOSENSIBILI A Der p 10. Allergeni maggiori
  • 52. Influenza della polisensibilizzazione a molecole degli acari sul livello di IgE specifiche per estratti Il livello medio di IgE specifiche per estratto (D1) è strettamente correlato al numero di molecole riconosciute al paziente (p< 0,0001) 0 10 20 30 40 50 60 0 1 2 3 4 num molecole Media RAST d1 kU/L
  • 53. Significato clinico della polisensibilizzazione ad allergeni di acari Il rischio di asma bronchiale aumenta con il numero di molecole a cui il paziente è sensibilizzato. La severità della sintomatologia asmatica è in funzione del numero di molecole a cui il paziente è sensibile 0,00% 10,00% 20,00% 30,00% 40,00% 50,00% 60,00% 70,00% 0 1 2 3 4 num molecole %ASMATICI r: 0,844; p < 0.05
  • 54. Prevalenza di sensibilizzazione alle singole molecole in asmatici e non Tutti i pazienti Monosensibili acari La presenza di asma si associa con la sensibilizzazione a Der p 2, Der p 10 e Der p 23. Nei pazienti monosensibili la presenza di asma si associa con la sensibilizzazione al solo Der p 23.